Cleared Traditional

125 I FOLATE SOLID PHASE RADIOASSAY (K792167) - FDA 510(k) Clearance

Class II Chemistry device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K792167 · Abbott Laboratories · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1979
Decision
18d
Days
Class 2
Risk

K792167 is an FDA 510(k) clearance for the 125 I FOLATE SOLID PHASE RADIOASSAY. Classified as Acid, Folic, Radioimmunoassay (product code CGN), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on November 13, 1979 after a review of 18 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1295 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Laboratories devices

Submission Details

510(k) Number K792167 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 26, 1979
Decision Date November 13, 1979
Days to Decision 18 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 88d · This submission: 18d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGN Acid, Folic, Radioimmunoassay
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1295
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGN Acid, Folic, Radioimmunoassay

All 33
Devices cleared under the same product code (CGN) and FDA review panel - the closest regulatory comparables to K792167.
SOLID PHASE SIMUL TRAC VITAMIN B12
K822728 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Nov 1982
QUANTA PHASE VITAMIN B-12/FOLATE RAD
K811177 · Bio-Rad · May 1981
'NO-BOIL' DUALCOUNT KIT
K810001 · Diagnostic Products Corp. · Jan 1981
FOLATE REAGENT KIT, ARIA-II SYSTEM
K780557 · Bd Becton Dickinson Vacutainer Systems Preanalytic · May 1978
PROCEDURE, RED CELL FOLATE ASSAY
K760133 · Bio-Rad · Jul 1976